2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1760481410 MD
Verify on CMS →

Jonathan Anolik, MD

Endocrinology, Diabetes & Metabolism Physician in Philadelphia, Pennsylvania.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 8,078 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
4K
Medicare Part D claims · 381 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
55%
generic claims · 40% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
85.3/100
▲ 2 pts above national avg 83.5 · Above neutral

What the federal data shows

Jonathan Anolik, MD reported a CMS MIPS final score of 85.3/100 - above the 83.5 national average - and filed 3,921 Medicare Part D claims in 2024.

85.3/100
MIPS score · +2 vs avg
4K
Part D claims, 2024
55%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Federal trust snapshot

What official records show about Jonathan Anolik, MD

Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.

  • Verified

    NPI registry status

    Active listing in the CMS National Provider Identifier Registry (NPI 1760481410), first enumerated 07/15/2005.

    Source: CMS NPPES

  • Reported

    Medicare Part D participation

    Filed 3,921 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.

    Source: CMS Part D Prescriber PUF

  • Reported

    CMS quality reporting (MIPS)

    Reported a CMS MIPS final score of 85.3/100 in the Quality Payment Program — a federal quality measure, not a patient review.

    Source: CMS Quality Payment Program

  • Reported

    Board certification signal

    Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.

    Source: NUCC taxonomy + CMS participation heuristic

  • Reported

    Hospital affiliations

    2 CMS Care Compare hospital affiliations on record — practice footprint from the Doctors and Clinicians file.

    Source: CMS Care Compare

  • State context

    State board disciplinary context

    Pennsylvania statewide board action statistics are published annually — these figures describe aggregate state activity, not Jonathan Anolik, MD's individual license status. Verify directly with the state medical board.

    Source: PA-BOM annual report 2023

  • Not in federal data

    Individual sanction lookup

    PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.

    Source: State medical board / FSMB

This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.

CMS NPPES provider registry desk

NPI 1760481410 · Endocrinology, Diabetes & Metabolism Physician

NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-INLINE · RX-MID · BOOK-THIN · PHOTO-FINISH

  • NPI-10 1760481410
  • ENUM-LEGACY 2005
  • TAX-MID 8K Endocrinology, Diabetes
  • MIPS-INLINE 85.3/100
  • RX-MID 3,921
  • BOOK-THIN 379 in Pennsylvania
  • PHOTO-FINISH Abel Alfonso, DO · ±0.0

MIPS final-score neighbourhood

Same-specialty nationwide peers by CMS final score, not geographic proximity

MIPS pts

What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).

Source CMS Quality Payment Program (MIPS) As of 2023

Jonathan Anolik, MD's MIPS score vs every measured U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.

85 ≥ 46th percentile 46% of 454,083 measured providers are in lower value bands

0–10: 8,684 measured providers (2%). Below this entry. 10–20: 3,008 measured providers (1%). Below this entry. 20–30: 3,069 measured providers (1%). Below this entry. 30–40: 2,746 measured providers (1%). Below this entry. 40–50: 2,928 measured providers (1%). Below this entry. 50–60: 5,882 measured providers (1%). Below this entry. 60–70: 13,906 measured providers (3%). Below this entry. 70–80: 94,570 measured providers (21%). Below this entry. 80–90: 129,887 measured providers (29%). This entry sits in this band. 90+: 189,403 measured providers (42%). Above this entry. This provider 0 100 every measured MIPS clinician, bucketed by value

Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Where Jonathan Anolik, MD sits

This provider among endocrinology, diabetes & metabolism physician peers

Across the 2,341 endocrinology, diabetes & metabolism physician providers who report both Medicare Part D prescribing and a MIPS quality score, Jonathan Anolik, MD writes more Part D claims than 72% of them and scores higher on MIPS quality than 49% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.

Lower volume · High qualityHigh volume · High qualityLower volume · Lower qualityHigh volume · Lower quality02550751000255075100Part D claim volume, percentile in specialtyMIPS quality, percentilePoint, Part D claim volume, percentile in specialty: 45 · MIPS quality, percentile: 80Point, Part D claim volume, percentile in specialty: 62 · MIPS quality, percentile: 77Point, Part D claim volume, percentile in specialty: 68 · MIPS quality, percentile: 70Point, Part D claim volume, percentile in specialty: 80 · MIPS quality, percentile: 40Point, Part D claim volume, percentile in specialty: 30 · MIPS quality, percentile: 50Point, Part D claim volume, percentile in specialty: 53 · MIPS quality, percentile: 58Point, Part D claim volume, percentile in specialty: 33 · MIPS quality, percentile: 23Point, Part D claim volume, percentile in specialty: 2 · MIPS quality, percentile: 40Point, Part D claim volume, percentile in specialty: 7 · MIPS quality, percentile: 95Point, Part D claim volume, percentile in specialty: 12 · MIPS quality, percentile: 23Point, Part D claim volume, percentile in specialty: 85 · MIPS quality, percentile: 32Point, Part D claim volume, percentile in specialty: 97 · MIPS quality, percentile: 67Point, Part D claim volume, percentile in specialty: 20 · MIPS quality, percentile: 87Point, Part D claim volume, percentile in specialty: 47 · MIPS quality, percentile: 3Point, Part D claim volume, percentile in specialty: 63 · MIPS quality, percentile: 35Point, Part D claim volume, percentile in specialty: 37 · MIPS quality, percentile: 47Point, Part D claim volume, percentile in specialty: 87 · MIPS quality, percentile: 78Point, Part D claim volume, percentile in specialty: 23 · MIPS quality, percentile: 13Point, Part D claim volume, percentile in specialty: 22 · MIPS quality, percentile: 92Point, Part D claim volume, percentile in specialty: 0 · MIPS quality, percentile: 98Point, Part D claim volume, percentile in specialty: 50 · MIPS quality, percentile: 12Point, Part D claim volume, percentile in specialty: 83 · MIPS quality, percentile: 22Point, Part D claim volume, percentile in specialty: 13 · MIPS quality, percentile: 98Point, Part D claim volume, percentile in specialty: 92 · MIPS quality, percentile: 68Point, Part D claim volume, percentile in specialty: 28 · MIPS quality, percentile: 93Point, Part D claim volume, percentile in specialty: 52 · MIPS quality, percentile: 90Point, Part D claim volume, percentile in specialty: 38 · MIPS quality, percentile: 7Point, Part D claim volume, percentile in specialty: 55 · MIPS quality, percentile: 62Point, Part D claim volume, percentile in specialty: 3 · MIPS quality, percentile: 20Point, Part D claim volume, percentile in specialty: 42 · MIPS quality, percentile: 5Point, Part D claim volume, percentile in specialty: 57 · MIPS quality, percentile: 48Point, Part D claim volume, percentile in specialty: 25 · MIPS quality, percentile: 53Point, Part D claim volume, percentile in specialty: 77 · MIPS quality, percentile: 33Point, Part D claim volume, percentile in specialty: 58 · MIPS quality, percentile: 73Point, Part D claim volume, percentile in specialty: 60 · MIPS quality, percentile: 45Point, Part D claim volume, percentile in specialty: 40 · MIPS quality, percentile: 83Point, Part D claim volume, percentile in specialty: 32 · MIPS quality, percentile: 38Point, Part D claim volume, percentile in specialty: 98 · MIPS quality, percentile: 57Point, Part D claim volume, percentile in specialty: 72 · MIPS quality, percentile: 83Point, Part D claim volume, percentile in specialty: 88 · MIPS quality, percentile: 72Point, Part D claim volume, percentile in specialty: 10 · MIPS quality, percentile: 18Point, Part D claim volume, percentile in specialty: 100 · MIPS quality, percentile: 97Point, Part D claim volume, percentile in specialty: 93 · MIPS quality, percentile: 28Point, Part D claim volume, percentile in specialty: 43 · MIPS quality, percentile: 65Point, Part D claim volume, percentile in specialty: 5 · MIPS quality, percentile: 37Point, Part D claim volume, percentile in specialty: 67 · MIPS quality, percentile: 27Point, Part D claim volume, percentile in specialty: 70 · MIPS quality, percentile: 80Point, Part D claim volume, percentile in specialty: 95 · MIPS quality, percentile: 10Point, Part D claim volume, percentile in specialty: 65 · MIPS quality, percentile: 30Point, Part D claim volume, percentile in specialty: 18 · MIPS quality, percentile: 88Point, Part D claim volume, percentile in specialty: 73 · MIPS quality, percentile: 43Point, Part D claim volume, percentile in specialty: 48 · MIPS quality, percentile: 63Point, Part D claim volume, percentile in specialty: 82 · MIPS quality, percentile: 52Point, Part D claim volume, percentile in specialty: 90 · MIPS quality, percentile: 75Point, Part D claim volume, percentile in specialty: 17 · MIPS quality, percentile: 0Point, Part D claim volume, percentile in specialty: 78 · MIPS quality, percentile: 2Point, Part D claim volume, percentile in specialty: 35 · MIPS quality, percentile: 60Point, Part D claim volume, percentile in specialty: 8 · MIPS quality, percentile: 17Point, Part D claim volume, percentile in specialty: 27 · MIPS quality, percentile: 8Point, Part D claim volume, percentile in specialty: 15 · MIPS quality, percentile: 15Jonathan Anolik, MD, Part D claim volume, percentile in specialty: 72 · MIPS quality, percentile: 49
Part D claim volume vs MIPS quality, by specialty percentile

Each dot is one endocrinology, diabetes & metabolism physician peer from a representative sample of 60; the gold marker is Jonathan Anolik, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.

Board certification likely (heuristic, not verified)

Jonathan Anolik, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Jonathan Anolik, MD?

High performer (top quartile)

NPI registry status

Active

Issued 07/15/2005

NPI 1760481410

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

8,078 US NPIs in this specialty

Medicare Part D claims

3,921 43% vs specialty avg

2024 prescription claims

Specialty avg: 2,739

MIPS final score

85.3/100 1.8 pts vs avg

Above neutral band

vs 83.5 national avg

Specialty distribution in Pennsylvania

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Pennsylvania providers

Pennsylvania providers
Student in an Organized Heal…6%Pharmacist5%Physical Therapist4.8%Mental Health Counselor4%Internal Medicine Physician3.3%Professional Counselor3.2%Endocrinology, Diabetes & Me…0.1%
Largest specialties in Pennsylvania (% of in-state providers)

Medicare quality performance, MIPS

Jonathan Anolik, MD's 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average

High performer (top quartile)
MIPS Final Score
85.3/100
vs 83.5 national avg · 2023 performance year
0%100%National avg84%85.3%
MIPS final score (Endocrinology, Diabetes & Metabolism Physician) - 85.3/100 vs national avg 83.5
How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Practice Address

3401 N BROAD ST
Philadelphia, PA 19140

Provider Details

NPI 1760481410
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials MD
Gender Male
NPI Issued 07/15/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

85.272
Final Score
Measured-score avg: 83.5
62.5541
Quality
75.2953
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where Jonathan Anolik, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Temple Faculty Practice Plan Inc
Philadelphia, PA
Temple Physicians Inc
Philadelphia, PA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context - Pennsylvania PA-BOM 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 - they are NOT specific to Jonathan Anolik, MD. To verify Jonathan Anolik, MD's current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases

PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

Jonathan Anolik, MD - brand share 40.0%
Endocrinology, Diabetes & Metabolism Physician average

40% brand-name claims vs 55% generic, on 3,921 2024 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2024.

3,921
Total Claims
$1.8M
Total Drug Cost
381
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
8,711.7
Total Day Supply
259,260
Brand vs Generic
40% brand / 55% generic
Brand Drug Cost
$1.7M
Generic Drug Cost
$46K

Patient Demographics

Average Patient Age
72.2 years
Avg HCC Risk Score
1.76
Gender Split
64% female / 36% male
Age Distribution
<65: 45, 65-74: 177, 75-84: 133, 85+: 26

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.

What Jonathan Anolik, MD prescribes most

Top Medicare Part D drugs by claim count, 2024

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2024
Drug Claims
Levothyroxine Sodium
369
Ozempic
Semaglutide
199
Trulicity
Dulaglutide
172
Metformin Hcl Er
Metformin Hcl
169
Atorvastatin Calcium
168
Synthroid
Levothyroxine Sodium
167
Rosuvastatin Calcium
136
Metformin Hcl
127
Jardiance
Empagliflozin
111
Ezetimibe
103

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How Jonathan Anolik, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

8,078
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,739
Avg Claims per Provider

Jonathan Anolik, MD's 3,921 claims are above the specialty average of 2,739.

Nationwide Endocrinology, Diabetes & Metabolism Physician peers with similar MIPS or enrollment year

Two federal-record peer sets for Anolik, both outside Pennsylvania so the neighborhoods are not geographic containment.

Similar MIPS final score

Nearest same-specialty clinicians by CMS MIPS final score (85.3 here).

Same NPPES enumeration year (2005)

Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Pennsylvania

Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as Anolik.

One of 379 Endocrinology, Diabetes & Metabolism Physician providers enrolled in Pennsylvania, 5 are shown here.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is Jonathan Anolik, MD's specialty?
Jonathan Anolik, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Philadelphia, Pennsylvania. Credentials: MD.
How much does Jonathan Anolik, MD prescribe under Medicare Part D?
In 2024, Jonathan Anolik, MD wrote 3,921 Medicare Part D claims totaling $1.8M in drug costs for 381 beneficiaries.
What is Jonathan Anolik, MD's Medicare quality score?
Jonathan Anolik, MD has a CMS MIPS Final Score of 85.3/100 (Quality: 62.6, Cost: 75.3). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Jonathan Anolik, MD located?
Jonathan Anolik, MD is located at 3401 N BROAD ST, Philadelphia, PA, 19140. Phone: (215) 707-4600.
What is Jonathan Anolik, MD's NPI number?
Jonathan Anolik, MD's National Provider Identifier (NPI) is 1760481410, issued on 07/15/2005.
Does Jonathan Anolik, MD prescribe more brand-name or generic drugs?
Jonathan Anolik, MD's prescribing is 40% brand-name and 55% generic drugs by claim count, with $1.7M in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 8,078 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,739 Medicare Part D claims per year.
What drugs does Jonathan Anolik, MD prescribe most often?
Based on 2024 Medicare Part D data, Jonathan Anolik, MD's most frequently prescribed drugs include Levothyroxine Sodium, Ozempic, Trulicity. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Jonathan Anolik, MD accept Medicare?
Jonathan Anolik, MD appears in CMS Medicare data with 3,921 Part D claims and 381 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Jonathan Anolik, MD's credentials?
Jonathan Anolik, MD's NPI is 1760481410 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.